Strategies for successful commercial-readiness in gene therapy

Insights from Orchard’s HSC gene therapy supply chain development

Another record year for cell and gene therapies?

Pipeline continues to expand along with regulatory decisions

Supporting transformational treatments for rare disorders

A Rare Disease Day retrospective

Advancements in Cell and Gene Therapy: 2019 Year-in-Review

Cell collection standards for cell therapies

A case study from the Standards Coordinating Body developed in partnership with Be The Match BioTherapies

Driving CAR-T therapy safety and sustainability for the road ahead

Q&A with Abby McDonald, PhD, Solutions Development Supervisor

The benefits of a Quality System Audit Program

Accelerate patient access to cell and gene therapies

Standardization in cell therapy industry is a race against time

Accellerate Summit highlights needs and challenges in standardization

The challenge of multiple audits and redundant training

A case study from UCLA Health